Literature DB >> 35238985

[Bacterial hepatobiliary infections : Pathogen spectrum, antimicrobial resistance and current treatment concepts].

Tony Bruns1, Andreas Stallmach2.   

Abstract

Ascending cholangitis and pyogenic liver abscesses are acute febrile bacterial hepatobiliary diseases. Nowadays they frequently occur in patients with structural changes of the biliary system and are usually treated by a combination of interventional drainage procedures and antimicrobial therapy. While Gram-negative Enterobacterales were identified as major causes in the past, biliary tract interventions and antibiotic exposure have contributed to an increase in enterococcal species and extended spectrum beta-lactamase (ESBL)-producing Enterobacterales. When selecting an appropriate empirical treatment the treating internist must consider local and individual risk factors for antimicrobial resistance in addition to pharmacokinetic aspects and disease severity to reduce the likelihood of treatment failure.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Antibiotics; Cholangitis; Intra-abdominal infection; Liver abscess; Resistance

Mesh:

Substances:

Year:  2022        PMID: 35238985     DOI: 10.1007/s00108-022-01277-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  63 in total

1.  Pyogenic liver abscess: current status and predictive factors for recurrence and mortality of first episodes.

Authors:  Matías E Czerwonko; Pablo Huespe; Santiago Bertone; Pablo Pellegrini; Oscar Mazza; Juan Pekolj; Eduardo de Santibañes; Sung Ho Hyon; Martín de Santibañes
Journal:  HPB (Oxford)       Date:  2016-10-03       Impact factor: 3.647

2.  High prevalence of multidrug-resistant bacteria in patients with pyogenic liver abscess following liver cancer loco-regional treatments.

Authors:  Francesca Colapietro; Chiara Masetti; Roberto Ceriani; Paola Morelli; Dario Poretti; Vittorio Pedicini; Nicola Pugliese; Antonio Voza; Ana Lleo; Alessio Aghemo
Journal:  Liver Int       Date:  2021-05-09       Impact factor: 5.828

3.  Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscess.

Authors:  D Bettinger; D Martin; S Rieg; M Schultheiss; N Buettner; R Thimme; T Boettler
Journal:  Aliment Pharmacol Ther       Date:  2018-01-12       Impact factor: 8.171

4.  Initial presentations and final outcomes of primary pyogenic liver abscess: a cross-sectional study.

Authors:  Chang-Hua Chen; Shung-Sheng Wu; Hung-Chi Chang; Yu-Jun Chang
Journal:  BMC Gastroenterol       Date:  2014-07-28       Impact factor: 3.067

5.  Cryptogenic and non-cryptogenic liver abscess: A retrospective analysis of 178 cases revealed distinct characteristics.

Authors:  Jing Chen; Minwei Zhang; Jinlong Chen; Yaogui Ning; Xiaoyang Cai; Li Zhang; Hao Xu; Jing Guo
Journal:  J Int Med Res       Date:  2018-08-09       Impact factor: 1.671

6.  Does vancomycin resistance increase mortality in Enterococcus faecium bacteraemia after orthotopic liver transplantation? A retrospective study.

Authors:  S Dubler; M Lenz; S Zimmermann; D C Richter; K H Weiss; A Mehrabi; M Mieth; T Bruckner; M A Weigand; T Brenner; A Heininger
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-31       Impact factor: 4.887

7.  Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates.

Authors:  Philip G Ferstl; Natalie Filmann; Eva-Maria Heilgenthal; Andreas A Schnitzbauer; Wolf O Bechstein; Volkhard A J Kempf; David Villinger; Tilman G Schultze; Michael Hogardt; Christoph Stephan; Haitham Mutlak; Nina Weiler; Marcus M Mücke; Jonel Trebicka; Stefan Zeuzem; Oliver Waidmann; Martin-Walter Welker
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

8.  Bacterial bile duct colonization in perihilar cholangiocarcinoma and its clinical significance.

Authors:  Jan Bednarsch; Zoltan Czigany; Lara Rosaline Heij; Tom Luedde; Ronald van Dam; Sven Arke Lang; Tom Florian Ulmer; Mathias Walter Hornef; Ulf Peter Neumann
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

9.  Calculated parenteral initial treatment of bacterial infections: Intra-abdominal infections.

Authors:  Christian Eckmann; Rainer Isenmann; Peter Kujath; Annette Pross; Arne C Rodloff; Franz-Josef Schmitz
Journal:  GMS Infect Dis       Date:  2020-03-26

10.  Calculated initial parenteral treatment of bacterial infections: Sepsis.

Authors:  Klaus-Friedrich Bodmann; Rainer Höhl; Wolfgang Krüger; Beatrice Grabein; Wolfgang Graninger
Journal:  GMS Infect Dis       Date:  2020-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.